Biomarkers reveal vital insights that could improve treatment strategies for aggressive prostate cancer, offering hope for ...

Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment. A new Phase 2 clinical ...

THOUSANDS more men should receive an existing prostate cancer drug on the NHS as research shows it could halve their death ...

Scientists say they have worked out a machine learning method with the ability to provide close to precise survival estimates ...

Exosomes transform prostate cancer care with early detection, tailored treatments, and real-time prognosis tracking for ...

Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

At the recent American Urological Association annual meeting, data on niraparib (Zejula) in treatment-naive, DNA damage ...

It's important to look carefully at the critiques prostate cancer screening guidelines and the role of PSA tests. There are ...

Prostate cancer is the most common cancer affecting American men other than skin cancer and the second leading cause of male ...

Scientists see a worrying rise in late-stage prostate cancer diagnoses. Experts say prostate cancer screening, once seen as ...

An FDA advisory committee on Wednesday unanimously voted against recommending approval of the PARP inhibitor talazoparib ...

Plus: Trump’s Surgeon General nominee and MAHA; and what Israeli officials are privately saying about starvation in Gaza.